TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Vivaderm AB
Closing information (x1000 SEK)
Closing information | 2024/12 | 2023/12 | 2022/12 |
Turnover |
905
|
1,064 | |
Financial expenses |
2
|
1 | |
Earnings before taxes |
73
|
136 | |
EBITDA |
150
|
212 | |
Total assets |
2,504
|
3,154 | |
Current assets |
647
|
1,223 | |
Current liabilities |
342
|
1,049 | |
Equity capital |
2,162
|
2,105 | |
- share capital |
100
![]() |
100 | |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Solvency |
86.3%
|
66.7% | |
Turnover per employee |
452
|
532 | |
Profit as a percentage of turnover |
8.1%
|
12.8% | |
Return on assets (ROA) |
3.0%
|
4.3% | |
Current ratio |
189.2%
|
116.6% | |
Return on equity (ROE) |
3.4%
|
6.5% | |
Change turnover |
-159
|
444 | |
Change turnover % |
2%
|
-15%
|
72% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2024/12 | 2023/12 | 2022/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.